Portfolio (Quarterly)
Guide ↗
CAXTON CORP
· CIK 0001388551| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GLD | SPDR GOLD TR | Financial Services | 6,964.0 | $2.8M | 64.50% | NEW | — | $396.31 | +6.0% |
| 2 | — | BERKSHIRE HATHAWAY INC DEL | — | 710.0 | $357K | 8.34% | NEW | — | $502.49 | — |
| 3 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 8,919.0 | $292K | 6.83% | NEW | — | $32.76 | +125.9% |
| 4 | — | MIND MEDICINE MINDMED INC | — | 15,688.0 | $210K | 4.91% | NEW | — | $13.39 | — |
| 5 | KYTX | KYVERNA THERAPEUTICS INC | Healthcare | 18,773.0 | $176K | 4.12% | NEW | — | $9.40 | -5.7% |
| 6 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 29,495.0 | $158K | 3.70% | NEW | — | $5.37 | -64.7% |
| 7 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 13,943.0 | $138K | 3.23% | NEW | — | $9.93 | -48.8% |
| 8 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 15,557.0 | $62K | 1.45% | NEW | — | $4.00 | -1.5% |
| 9 | — | INHIBIKASE THERAPEUTICS INC | — | 28,453.0 | $58K | 1.36% | NEW | — | $2.05 | — |
| 10 | — | SAB BIOTHERAPEUTICS INC | — | 10,527.0 | $39K | 0.92% | NEW | — | $3.74 | — |
| 11 | CNTX | CONTEXT THERAPEUTICS INC | Healthcare | 18,403.0 | $27K | 0.63% | NEW | — | $1.47 | +46.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Financial Services
76.4%
Healthcare
23.6%